BNP/CALL/MERCK & CO./130/0.1/19.12.25 Stock

Warrant

DE000PC1LLT0

Market Closed - Börse Stuttgart 03:32:13 2024-05-17 EDT
1.62 EUR -5.26% Intraday chart for BNP/CALL/MERCK & CO./130/0.1/19.12.25
Current month-0.61%
1 month+11.72%
Date Price Change
24-05-17 1.62 -5.26%
24-05-16 1.71 +13.25%
24-05-15 1.51 -1.31%
24-05-14 1.53 -3.77%
24-05-13 1.59 -0.63%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 03:32 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LLT
ISINDE000PC1LLT0
Date issued 2023-12-11
Strike 130 $
Maturity 2025-12-19 (580 Days)
Parity 10 : 1
Emission price 0.41
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.82
Lowest since issue 0.49
Delta0.6x
Omega 4.449
Premium12.6x
Gearing7.4x
Moneyness 1.009
Difference Strike -1.19 $
Difference Strike %-0.92%
Spread 0.02
Spread %1.22%
Theoretical value 1.630
Implied Volatility 23.37 %
Total Loss Probability 49.11 %
Intrinsic value 0.1095
Present value 1.521
Break even 147.72 €
Theta-0.01x
Vega0.06x
Rho0.09x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW